Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 18 | 2024 | 3599 | 0.950 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2024 | 8506 | 0.620 |
Why?
|
Neuroblastoma | 6 | 2024 | 1251 | 0.590 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2023 | 381 | 0.590 |
Why?
|
Principal Component Analysis | 4 | 2008 | 940 | 0.560 |
Why?
|
DNA, Mitochondrial | 3 | 2008 | 856 | 0.460 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2022 | 104 | 0.450 |
Why?
|
RNA-Binding Protein EWS | 6 | 2022 | 210 | 0.450 |
Why?
|
Bone Neoplasms | 6 | 2022 | 2531 | 0.420 |
Why?
|
Glycogen Synthase Kinase 3 | 4 | 2022 | 408 | 0.400 |
Why?
|
Gene Expression Profiling | 13 | 2017 | 9404 | 0.350 |
Why?
|
Xenograft Model Antitumor Assays | 13 | 2021 | 3574 | 0.340 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2018 | 555 | 0.320 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3609 | 0.320 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2022 | 1594 | 0.290 |
Why?
|
Cell Line, Tumor | 22 | 2024 | 16886 | 0.280 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3774 | 0.270 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5249 | 0.260 |
Why?
|
Creatine Kinase | 2 | 2018 | 686 | 0.260 |
Why?
|
I-kappa B Kinase | 2 | 2018 | 250 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2020 | 989 | 0.250 |
Why?
|
Drug Synergism | 5 | 2019 | 1745 | 0.240 |
Why?
|
Lymphoma, Follicular | 2 | 2005 | 453 | 0.230 |
Why?
|
Folic Acid | 2 | 2021 | 1309 | 0.230 |
Why?
|
Breast Neoplasms | 8 | 2014 | 21017 | 0.220 |
Why?
|
Sulfonamides | 3 | 2024 | 1973 | 0.210 |
Why?
|
Longevity | 2 | 2008 | 1050 | 0.210 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2023 | 174 | 0.200 |
Why?
|
Cystine | 1 | 2022 | 94 | 0.200 |
Why?
|
Lymphoma, B-Cell | 2 | 2006 | 935 | 0.200 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2024 | 477 | 0.200 |
Why?
|
Phylogeny | 2 | 2008 | 2774 | 0.200 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2021 | 32 | 0.190 |
Why?
|
Enzyme Inhibitors | 3 | 2023 | 3709 | 0.190 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 706 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 640 | 0.180 |
Why?
|
Cluster Analysis | 4 | 2008 | 2697 | 0.180 |
Why?
|
Indazoles | 2 | 2019 | 302 | 0.180 |
Why?
|
Immunologic Memory | 3 | 2017 | 1353 | 0.180 |
Why?
|
Meta-Analysis as Topic | 1 | 2005 | 1373 | 0.170 |
Why?
|
U937 Cells | 5 | 2020 | 262 | 0.170 |
Why?
|
Lymphocytes | 1 | 2007 | 2610 | 0.170 |
Why?
|
Gene Amplification | 3 | 2024 | 1085 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 8 | 2023 | 5629 | 0.170 |
Why?
|
Aminopyridines | 3 | 2019 | 564 | 0.170 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2019 | 646 | 0.160 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2006 | 1402 | 0.160 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 275 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2021 | 2413 | 0.160 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2019 | 119 | 0.160 |
Why?
|
Azepines | 2 | 2018 | 329 | 0.160 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2018 | 41 | 0.160 |
Why?
|
Cell Proliferation | 13 | 2021 | 10416 | 0.160 |
Why?
|
Signal Transduction | 14 | 2022 | 23342 | 0.160 |
Why?
|
Bepridil | 1 | 2018 | 12 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2018 | 345 | 0.150 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 677 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2017 | 45 | 0.150 |
Why?
|
Yellow Fever Vaccine | 1 | 2017 | 37 | 0.150 |
Why?
|
Phenylenediamines | 1 | 2018 | 86 | 0.150 |
Why?
|
Mice | 25 | 2024 | 81101 | 0.140 |
Why?
|
Trans-Activators | 2 | 2024 | 2860 | 0.140 |
Why?
|
Bone Marrow | 2 | 2019 | 2909 | 0.140 |
Why?
|
Receptor, erbB-2 | 1 | 2007 | 2553 | 0.140 |
Why?
|
Integrin beta3 | 2 | 2017 | 120 | 0.140 |
Why?
|
Cell Death | 2 | 2019 | 1668 | 0.140 |
Why?
|
Glioblastoma | 2 | 2010 | 3480 | 0.140 |
Why?
|
Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 10 | 0.140 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 724 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2017 | 4549 | 0.140 |
Why?
|
Animals | 33 | 2024 | 167768 | 0.130 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 380 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2015 | 2825 | 0.130 |
Why?
|
Proto-Oncogenes | 1 | 2017 | 320 | 0.130 |
Why?
|
Humans | 73 | 2024 | 758406 | 0.130 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2796 | 0.130 |
Why?
|
Proteomics | 4 | 2022 | 3816 | 0.130 |
Why?
|
Cell Cycle Proteins | 5 | 2021 | 3442 | 0.130 |
Why?
|
Clone Cells | 1 | 2019 | 1660 | 0.130 |
Why?
|
Cell Differentiation | 5 | 2017 | 11471 | 0.130 |
Why?
|
Triazoles | 2 | 2018 | 902 | 0.130 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2015 | 2416 | 0.130 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 230 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2018 | 495 | 0.120 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3754 | 0.120 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1825 | 0.120 |
Why?
|
Genomics | 3 | 2014 | 5790 | 0.120 |
Why?
|
Haplotypes | 4 | 2012 | 2764 | 0.120 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 350 | 0.120 |
Why?
|
Calcium Channel Blockers | 1 | 2018 | 694 | 0.120 |
Why?
|
Up-Regulation | 4 | 2017 | 4113 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2016 | 1171 | 0.120 |
Why?
|
Methotrexate | 1 | 2021 | 1719 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2018 | 719 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2015 | 2872 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2018 | 655 | 0.120 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2015 | 158 | 0.120 |
Why?
|
Neoplasms | 6 | 2020 | 22032 | 0.120 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2013 | 177 | 0.120 |
Why?
|
Chemokine CCL5 | 1 | 2014 | 215 | 0.110 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 184 | 0.110 |
Why?
|
Genome, Human | 4 | 2018 | 4416 | 0.110 |
Why?
|
Proteome | 1 | 2004 | 1855 | 0.110 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 933 | 0.110 |
Why?
|
RNA Interference | 4 | 2018 | 2836 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2016 | 4624 | 0.110 |
Why?
|
Cyclin D1 | 1 | 2015 | 451 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 704 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13591 | 0.110 |
Why?
|
Purines | 1 | 2016 | 605 | 0.110 |
Why?
|
Gene Duplication | 1 | 2014 | 313 | 0.110 |
Why?
|
Lactase | 1 | 2012 | 71 | 0.100 |
Why?
|
T-Lymphocytes | 5 | 2023 | 10171 | 0.100 |
Why?
|
Transcription Factors | 3 | 2017 | 12094 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 372 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 749 | 0.100 |
Why?
|
Embryo, Nonmammalian | 1 | 2015 | 900 | 0.100 |
Why?
|
Arenaviridae Infections | 1 | 2011 | 53 | 0.100 |
Why?
|
DNA Methylation | 5 | 2024 | 4373 | 0.090 |
Why?
|
Pyrimidines | 3 | 2018 | 3006 | 0.090 |
Why?
|
Genetic Markers | 2 | 2008 | 2608 | 0.090 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5786 | 0.090 |
Why?
|
Apoptosis | 7 | 2024 | 9468 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2010 | 8981 | 0.090 |
Why?
|
Mice, Nude | 4 | 2019 | 3602 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 772 | 0.090 |
Why?
|
HL-60 Cells | 3 | 2016 | 363 | 0.090 |
Why?
|
Hematopoiesis | 2 | 2019 | 2047 | 0.090 |
Why?
|
Histones | 2 | 2024 | 2577 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 998 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2015 | 12759 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3617 | 0.080 |
Why?
|
Vital Capacity | 1 | 2012 | 962 | 0.080 |
Why?
|
Pan paniscus | 1 | 2008 | 5 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2912 | 0.080 |
Why?
|
MicroRNAs | 3 | 2017 | 3783 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2015 | 606 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1392 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2013 | 719 | 0.080 |
Why?
|
Mutation | 10 | 2023 | 29915 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4406 | 0.080 |
Why?
|
Pan troglodytes | 1 | 2008 | 224 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 4938 | 0.080 |
Why?
|
Benzamides | 3 | 2019 | 1368 | 0.070 |
Why?
|
Antigen Presentation | 1 | 2013 | 1254 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 367 | 0.070 |
Why?
|
Genes, erbB-1 | 1 | 2008 | 160 | 0.070 |
Why?
|
Computer Simulation | 4 | 2017 | 6201 | 0.070 |
Why?
|
DNA Modification Methylases | 1 | 2008 | 209 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1044 | 0.070 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 204 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9273 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2057 | 0.070 |
Why?
|
Gene Dosage | 2 | 2010 | 1218 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1547 | 0.070 |
Why?
|
Cell Survival | 4 | 2021 | 5781 | 0.070 |
Why?
|
Neurofibromin 1 | 1 | 2008 | 190 | 0.070 |
Why?
|
Carcinoma, Ductal | 1 | 2007 | 97 | 0.070 |
Why?
|
Zebrafish | 4 | 2021 | 2993 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2004 | 4876 | 0.070 |
Why?
|
Transforming Growth Factor beta | 2 | 2019 | 1958 | 0.070 |
Why?
|
Exercise Tolerance | 1 | 2012 | 830 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1627 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2008 | 344 | 0.070 |
Why?
|
RNA, Small Interfering | 4 | 2018 | 3432 | 0.070 |
Why?
|
Genes, erbB-2 | 1 | 2007 | 162 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2016 | 15773 | 0.070 |
Why?
|
Dipeptides | 2 | 2018 | 386 | 0.070 |
Why?
|
Japan | 2 | 2008 | 1366 | 0.070 |
Why?
|
DNA Repair | 2 | 2021 | 2038 | 0.060 |
Why?
|
Phosphorylation | 4 | 2019 | 8297 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3796 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2008 | 394 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2019 | 1693 | 0.060 |
Why?
|
Logic | 1 | 2005 | 40 | 0.060 |
Why?
|
Diet, Gluten-Free | 1 | 2008 | 280 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1411 | 0.060 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2005 | 132 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2858 | 0.060 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5779 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2010 | 560 | 0.060 |
Why?
|
Discriminant Analysis | 1 | 2005 | 222 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 2 | 2010 | 3217 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2014 | 3208 | 0.060 |
Why?
|
Multigene Family | 1 | 2007 | 1076 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2021 | 638 | 0.060 |
Why?
|
Down-Regulation | 3 | 2018 | 2904 | 0.060 |
Why?
|
Computational Biology | 2 | 2007 | 3502 | 0.060 |
Why?
|
Female | 21 | 2021 | 390323 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1055 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 507 | 0.060 |
Why?
|
Cells | 1 | 2005 | 164 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2006 | 367 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2010 | 929 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2626 | 0.060 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 412 | 0.050 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1634 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1807 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2023 | 48 | 0.050 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2024 | 198 | 0.050 |
Why?
|
Kidney Neoplasms | 2 | 2010 | 4312 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3615 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 22003 | 0.050 |
Why?
|
Prognosis | 6 | 2021 | 29557 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6127 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2013 | 2723 | 0.050 |
Why?
|
Pattern Recognition, Automated | 2 | 2007 | 994 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2024 | 337 | 0.050 |
Why?
|
Daunorubicin | 1 | 2022 | 156 | 0.050 |
Why?
|
Sulfasalazine | 1 | 2022 | 84 | 0.050 |
Why?
|
Databases as Topic | 1 | 2004 | 472 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2176 | 0.050 |
Why?
|
Disease Progression | 3 | 2007 | 13468 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11709 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2010 | 4106 | 0.050 |
Why?
|
Prostatic Hyperplasia | 1 | 2006 | 530 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2019 | 1477 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2021 | 47 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2017 | 1553 | 0.050 |
Why?
|
Acetylation | 1 | 2024 | 1060 | 0.050 |
Why?
|
Calibration | 1 | 2004 | 814 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4567 | 0.050 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 1996 | 0.050 |
Why?
|
Models, Biological | 3 | 2010 | 9460 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 450 | 0.050 |
Why?
|
Laboratories | 1 | 2005 | 460 | 0.050 |
Why?
|
Histocompatibility Antigens | 1 | 2022 | 467 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15225 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4257 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 3997 | 0.050 |
Why?
|
Databases, Genetic | 1 | 2007 | 1737 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4738 | 0.050 |
Why?
|
beta Catenin | 2 | 2018 | 1043 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2008 | 1346 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4711 | 0.040 |
Why?
|
Biological Evolution | 1 | 2006 | 1074 | 0.040 |
Why?
|
NF-kappa B | 2 | 2022 | 2472 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12604 | 0.040 |
Why?
|
Diphenylamine | 1 | 2019 | 49 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1885 | 0.040 |
Why?
|
Adoptive Transfer | 2 | 2013 | 819 | 0.040 |
Why?
|
Celiac Disease | 1 | 2008 | 822 | 0.040 |
Why?
|
Genes, Neoplasm | 2 | 2016 | 370 | 0.040 |
Why?
|
Chromatin | 2 | 2024 | 2938 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9574 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 319 | 0.040 |
Why?
|
Protein Stability | 1 | 2021 | 566 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2006 | 2359 | 0.040 |
Why?
|
Ubiquitination | 1 | 2024 | 1006 | 0.040 |
Why?
|
Smad2 Protein | 1 | 2019 | 145 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 223 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2006 | 1096 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2007 | 2210 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6209 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2019 | 310 | 0.040 |
Why?
|
Radioisotope Dilution Technique | 1 | 2017 | 71 | 0.040 |
Why?
|
Models, Molecular | 1 | 2008 | 5410 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 802 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2008 | 2800 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Yellow fever virus | 1 | 2017 | 23 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 477 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4284 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5031 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2018 | 20055 | 0.040 |
Why?
|
Deuterium | 1 | 2017 | 105 | 0.040 |
Why?
|
Polymers | 1 | 2005 | 1616 | 0.040 |
Why?
|
Patient Compliance | 1 | 2008 | 2685 | 0.040 |
Why?
|
Algorithms | 4 | 2007 | 13961 | 0.040 |
Why?
|
Yellow Fever | 1 | 2017 | 54 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2005 | 1373 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 893 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1404 | 0.040 |
Why?
|
Karyotyping | 1 | 2019 | 1171 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 627 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2017 | 58683 | 0.030 |
Why?
|
Phenotype | 3 | 2015 | 16534 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2021 | 832 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 652 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2189 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1688 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2020 | 14354 | 0.030 |
Why?
|
Mitochondria | 2 | 2022 | 3584 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 814 | 0.030 |
Why?
|
Transfection | 2 | 2015 | 5779 | 0.030 |
Why?
|
Drug Resistance | 1 | 2022 | 1593 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 392 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1133 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 727 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 14641 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 723 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6493 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2006 | 1996 | 0.030 |
Why?
|
Models, Genetic | 1 | 2006 | 3441 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 778 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 714 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2015 | 154 | 0.030 |
Why?
|
Recurrence | 1 | 2007 | 8426 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2014 | 15 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 598 | 0.030 |
Why?
|
Sarcoma | 1 | 2006 | 1785 | 0.030 |
Why?
|
Genes, ras | 1 | 2017 | 654 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1356 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2007 | 22029 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1387 | 0.030 |
Why?
|
Base Sequence | 3 | 2013 | 12436 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7590 | 0.030 |
Why?
|
Artificial Intelligence | 2 | 2007 | 2551 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3384 | 0.030 |
Why?
|
Thiophenes | 1 | 2018 | 569 | 0.030 |
Why?
|
Pyrazines | 1 | 2019 | 1198 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 228 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2015 | 18940 | 0.030 |
Why?
|
Janus Kinases | 1 | 2014 | 249 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5246 | 0.030 |
Why?
|
Aged | 7 | 2017 | 168218 | 0.030 |
Why?
|
Adult | 9 | 2023 | 219935 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1694 | 0.030 |
Why?
|
Cell Cycle | 1 | 2021 | 2930 | 0.030 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2012 | 29 | 0.030 |
Why?
|
Middle Aged | 8 | 2017 | 219568 | 0.030 |
Why?
|
Quinazolines | 1 | 2019 | 1360 | 0.030 |
Why?
|
Male | 10 | 2020 | 358747 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2013 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 786 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2012 | 114 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 557 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2014 | 431 | 0.020 |
Why?
|
Child | 5 | 2022 | 79818 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2004 | 3561 | 0.020 |
Why?
|
Peptides | 1 | 2004 | 4341 | 0.020 |
Why?
|
Transgenes | 1 | 2015 | 1007 | 0.020 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 84 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1610 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1080 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2015 | 1900 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2012 | 377 | 0.020 |
Why?
|
Indoles | 1 | 2019 | 1828 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1705 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2012 | 296 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 300 | 0.020 |
Why?
|
Models, Statistical | 1 | 2005 | 5070 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 484 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 964 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2011 | 276 | 0.020 |
Why?
|
Software | 1 | 2004 | 4415 | 0.020 |
Why?
|
Kenya | 1 | 2012 | 749 | 0.020 |
Why?
|
Semaphorins | 1 | 2010 | 96 | 0.020 |
Why?
|
Cell Line | 2 | 2019 | 15591 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3593 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1893 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2014 | 1122 | 0.020 |
Why?
|
Genome | 1 | 2017 | 1739 | 0.020 |
Why?
|
Dexamethasone | 1 | 2016 | 1927 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5201 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1745 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6293 | 0.020 |
Why?
|
Fluorouracil | 1 | 2014 | 1631 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1006 | 0.020 |
Why?
|
Time Factors | 2 | 2015 | 39872 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6821 | 0.020 |
Why?
|
Tanzania | 1 | 2012 | 1383 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 800 | 0.020 |
Why?
|
Adolescent | 4 | 2008 | 87892 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 956 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1629 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13245 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1842 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 17617 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1680 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 999 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2001 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1991 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4641 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5864 | 0.020 |
Why?
|
Cell Communication | 1 | 2013 | 1651 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 931 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2693 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2262 | 0.020 |
Why?
|
Viral Vaccines | 1 | 2011 | 596 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3612 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9160 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3840 | 0.020 |
Why?
|
Walking | 1 | 2012 | 1188 | 0.020 |
Why?
|
Software Design | 1 | 2005 | 171 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2005 | 183 | 0.010 |
Why?
|
Dyspnea | 1 | 2012 | 1344 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1895 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2470 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2816 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6026 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 80168 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2492 | 0.010 |
Why?
|
Cholesterol | 1 | 2012 | 2902 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10748 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11336 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5490 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10718 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 712 | 0.010 |
Why?
|
Viral Load | 1 | 2011 | 3321 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15785 | 0.010 |
Why?
|
Reference Standards | 1 | 2006 | 1003 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2013 | 3485 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11070 | 0.010 |
Why?
|
Molecular Structure | 1 | 2005 | 1866 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2504 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7225 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4458 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12951 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12721 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2005 | 748 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9518 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3322 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9416 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4087 | 0.010 |
Why?
|
Protein Kinases | 1 | 2005 | 1610 | 0.010 |
Why?
|
Prostate | 1 | 2006 | 1791 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10495 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3216 | 0.010 |
Why?
|
Gene Expression | 1 | 2010 | 7583 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7338 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9267 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 73809 | 0.010 |
Why?
|
Alleles | 1 | 2006 | 6895 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17768 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2012 | 64378 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4485 | 0.010 |
Why?
|
Age Factors | 1 | 2006 | 18358 | 0.010 |
Why?
|
Databases, Factual | 1 | 2005 | 7980 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23679 | 0.000 |
Why?
|
Cohort Studies | 1 | 2010 | 41256 | 0.000 |
Why?
|
Quality of Life | 1 | 2008 | 13285 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42062 | 0.000 |
Why?
|